◆英語タイトル:West Pharmaceutical Services Inc (WST) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8011939
◆発行会社(調査会社):
GlobalData
◆発行日:2017年12月14日
◆ページ数:54
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
※
販売価格オプションの説明はこちらで、
ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※
GlobalData社の概要はこちらでご確認いただけます。
【レポートの概要】
Summary
West Pharmaceutical Services Inc (West Pharmaceutical) manufactures components and systems for packaging and delivery of injectable drugs and delivery system components for use healthcare, pharmaceuticals and consumer product industries. Its product and services include stoppers and seals for vials, components for intravenous and blood collection systems, prefillable syringe components and systems, advanced injection systems, safety and administration systems, contract design and manufacturing services. The company caters its products to pharmaceutical, biotechnology, generic drug and medical devices companies. It has manufacturing facilities in North America, South America, Europe and Asia-Pacific with affiliated companies in Mexico and Japan. West Pharmaceutical is headquartered in Exton, Pennsylvania, the US.
West Pharmaceutical Services Inc (WST) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.
Scope
- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.
Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
West Pharmaceutical Services Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 6
West Pharmaceutical Services Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 7
West Pharmaceutical Services Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 8
West Pharmaceutical Services Inc, Medical Equipment, Deals By Market, 2011 to YTD 2017 9
West Pharmaceutical Services Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 10
West Pharmaceutical Services Inc, Medical Equipment, Deal Details 11
Partnerships 11
Gerresheimer Enters into Licensing Agreement with West Pharma 11
West Pharma Enters Into Co-Development Agreement With Janssen Biotech 12
West Pharma Enters Into Agreement With CareFusion 13
Debt Offering 14
West Pharma Completes Private Placement Of 3.67% Series A Senior Notes Due 2022 For US$42 Million 14
West Pharma Completes Private Placement Of 3.82% Series B Senior Notes Due 2024 For US$53 Million 15
West Pharma Completes Private Placement Of Series C Senior Notes Due 2027 For US$73 Million 16
Acquisition 17
West Pharma Invests in NanoPass Technologies 17
West Pharmaceutical Services Inc – Key Competitors 18
West Pharmaceutical Services Inc – Key Employees 19
West Pharmaceutical Services Inc – Locations And Subsidiaries 21
Head Office 21
Other Locations & Subsidiaries 21
Recent Developments 23
Strategy And Business Planning 23
Nov 29, 2016: West Announces Expanded Contract Manufacturing Capabilities in Ireland 23
Jan 20, 2016: West and Noble Collaborate to Improve Patient Education and Training for Self-Injection Systems 24
Financial Announcements 25
Oct 26, 2017: West Announces Third-Quarter 2017 Results 25
Jul 27, 2017: West Announces Second-Quarter 2017 Results 27
Apr 27, 2017: West Announces First-Quarter 2017 Results 29
Feb 16, 2017: West Announces Fourth-Quarter and Full-Year 2016 Results and Announces Quarterly Dividend 31
Oct 27, 2016: West Announces Third Quarter 2016 Results 34
Jul 28, 2016: West Announces Second Quarter 2016 Results 36
Apr 28, 2016: West Announces First Quarter 2016 Results 38
Feb 18, 2016: West Announces Fourth Quarter and Full-Year 2015 Results 40
Corporate Communications 43
Jun 01, 2017: West Elects New Director to the Board 43
Sep 26, 2016: West Appoints David A. Montecalvo Senior Vice President, Global Operations and Supply Chain 44
Sep 12, 2016: West Elects New Director and Announces Increase to Quarterly Dividend 45
Mar 01, 2016: West Appoints Eric Resnick to Chief Technology Officer 46
Product News 47
May 30, 2017: West to Present on Biologics Trends at InnoPack Pharma Confex 47
May 03, 2017: West Highlights Company Scientific and Regulatory Expertise at Notable Industry Meetings 48
Oct 17, 2016: West to Showcase Expertise in Injectable Drug Containment and Delivery at PDA Universe of Pre-filled Syringes & Injection Devices 50
Jun 07, 2016: West Introduces 1-3mL NovaPure Plunger for Higher Volume Injections 52
Other Significant Developments 53
Feb 12, 2016: West’s Daikyo Crystal Zenith Cyclic Olefin Polymer Selected by Amgen 53
Appendix 54
Methodology 54
About GlobalData 54
Contact Us 54
Disclaimer 54
List of Tables
West Pharmaceutical Services Inc, Medical Equipment, Key Facts, 2016 2
West Pharmaceutical Services Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
West Pharmaceutical Services Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 6
West Pharmaceutical Services Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 7
West Pharmaceutical Services Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 8
West Pharmaceutical Services Inc, Deals By Market, 2011 to YTD 2017 9
West Pharmaceutical Services Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 10
Gerresheimer Enters into Licensing Agreement with West Pharma 11
West Pharma Enters Into Co-Development Agreement With Janssen Biotech 12
West Pharma Enters Into Agreement With CareFusion 13
West Pharma Completes Private Placement Of 3.67% Series A Senior Notes Due 2022 For US$42 Million 14
West Pharma Completes Private Placement Of 3.82% Series B Senior Notes Due 2024 For US$53 Million 15
West Pharma Completes Private Placement Of Series C Senior Notes Due 2027 For US$73 Million 16
West Pharma Invests in NanoPass Technologies 17
West Pharmaceutical Services Inc, Key Competitors 18
West Pharmaceutical Services Inc, Key Employees 19
West Pharmaceutical Services Inc, Other Locations 21
West Pharmaceutical Services Inc, Subsidiaries 21